SONNET BIOTHERAPEUTICS

Serial Number 90172153
Registration 6790475
700

Registration Progress

Application Filed
Sep 10, 2020
Under Examination
Apr 27, 2021
Approved for Publication
Mar 2, 2021
Published for Opposition
Mar 2, 2021
Registered
Jul 12, 2022

Trademark Image

SONNET BIOTHERAPEUTICS

Basic Information

Serial Number
90172153
Registration Number
6790475
Filing Date
September 10, 2020
Registration Date
July 12, 2022
Published for Opposition
March 2, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 12, 2022
Registration
Registered
Classes
005 042

Rights Holder

Sonnet BioTherapeutics, Inc.

03
Address
100 Overlook Center
Princeton, NJ 08540

Ownership History

Sonnet BioTherapeutics, Inc.

Original Applicant
03
Princeton, NJ

Sonnet BioTherapeutics, Inc.

Owner at Publication
03
Princeton, NJ

Sonnet BioTherapeutics, Inc.

Original Registrant
03
Princeton, NJ

Legal Representation

Attorney
Sharon R. Smith

USPTO Deadlines

Next Deadline
1085 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-07-12)
Due Date
July 12, 2028
Grace Period Ends
January 12, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Jul 12, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 12, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 9, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 8, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 17, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 17, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 5, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
May 5, 2022 IUAF S USE AMENDMENT FILED Loading...
Apr 20, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 18, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 18, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 18, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 12, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 8, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 8, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 8, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 27, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 2, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 2, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 10, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 26, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 26, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 26, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 26, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 26, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 20, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 16, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 14, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceuticals for the treatment of cancer
First Use Anywhere: Mar 22, 2022
First Use in Commerce: Mar 22, 2022
Class 042
research and development for the treatment of cancer
First Use Anywhere: Oct 12, 2015
First Use in Commerce: Oct 12, 2015

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOTHERAPEUTICS"